CN101428080B - Health care essential oil of magnolia flower - Google Patents
Health care essential oil of magnolia flower Download PDFInfo
- Publication number
- CN101428080B CN101428080B CN2008102198327A CN200810219832A CN101428080B CN 101428080 B CN101428080 B CN 101428080B CN 2008102198327 A CN2008102198327 A CN 2008102198327A CN 200810219832 A CN200810219832 A CN 200810219832A CN 101428080 B CN101428080 B CN 101428080B
- Authority
- CN
- China
- Prior art keywords
- oil
- magnolia flower
- essential oil
- care essential
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a magnolia flower health-care essential oil. The magnolia flower health-care essential oil comprises 70-95 percent of base oil and 5-30 percent of Chinese herbal medicine composition. The Chinese herbal medicine composition comprises olibanum, Chinese angelica, Chinese cinnamon, chuanxiong rhizome, myrrh, notoperygium root, nodular branch of pine, folium eucalypti, mint and magnolia flower with equal proportion. The invention utilizes the characteristics of the magnolia flower with spiciness dispersing, arome flying and strong percolating force, and greatly enhances the effects of activating blood and dissolving stasis and expelling wind and dispelling cold of other drugs, thereby the effects of reducing swelling and removing pain can be rapidly achieved; and meanwhile, the arome has no penetrating odor of other oil, and the essential oil can be externally used for any part (except for eyes) of the human body, and can be widely suitable for sprain and pain of various muscles and bones and soft tissues.
Description
Technical field
This aspect relates to a kind of blood circulation promoting and blood stasis dispelling analgesic health care essential oil of magnolia flower.
Background technology
Blood circulation promoting and blood stasis dispelling analgesic lubricate in the prior art, penetration is poor, can't reach analgesic effect quickly.And its abnormal smells from the patient and stimulate greatlyyer to the crowd of abnormal smells from the patient sensitivity, is smelt the back and is easily produced belch, singultus, even dizzy, simultaneously in some sensitive part, as trunk and neural abundant position, can't use, otherwise will produce sensation such as peppery pain.
Summary of the invention
The objective of the invention is to overcome above-mentioned defective, a kind of health care essential oil of magnolia flower is provided.
In order to achieve the above object, a kind of health care essential oil of magnolia flower of the present invention, its raw material are A, B component; Wherein the A component is a base oil, accounts for 70%-95%, is Rosehips oil, Radix Oenotherae erythrosepalae oil and Semen pruni armeniacae oil, and three's ratio is 1: 2: 2; B component proportion is 5%-30%, is Olibanum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Chuanxiong, Myrrha, Rhizoma Et Radix Notopterygii, Lignum Pini Nodi, Folium eucalypti globueli (Eucalyptus globulus Labill.), Herba Menthae and the Flos Magnoliae of ratio equal portions.
The optimum scope of A of the present invention, B component is respectively: 90%-95% and 5%-10%.
Flos Magnoliae generally is used for the treatment of nasosinusitis headache.The present invention utilizes the characteristics that the diffusing temperature of the suffering of Flos Magnoliae is logical, fragrance is walked to scurry, penetration is strong, has strengthened the blood circulation promoting and blood stasis dispelling of other medicines, the effect of expelling wind and cold greatly, thereby can reach the effect of Repercusion analgesia soon.Simultaneously its fragrance and do not have the penetrating odor of other lubricate can be used for any position (except the eyes) of human body outward, is widely used in spraining and pain of each analgesic bone and soft tissue.
The specific embodiment
Embodiment 1:
A; Rosehips oil 15% Radix Oenotherae erythrosepalae oil 30% Semen pruni armeniacae oil 30%
B: Olibanum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Chuanxiong, Myrrha, Rhizoma Et Radix Notopterygii, Lignum Pini Nodi, Folium eucalypti globueli (Eucalyptus globulus Labill.) Herba Menthae Flos Magnoliae mentioned component account for 25% altogether in 1: 1 ratio;
Utilize the supercritical CO 2 abstraction technique, isolate the effective ingredient of each medicine in the B component, mix with three kinds of base oils of A component then, can obtain quintessence oil of the present invention.
Embodiment 2:
A; Rosehips oil 17% Radix Oenotherae erythrosepalae oil 34% Semen pruni armeniacae oil 34%
B: Olibanum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Chuanxiong, Myrrha, Rhizoma Et Radix Notopterygii, Lignum Pini Nodi, Folium eucalypti globueli (Eucalyptus globulus Labill.) Herba Menthae Flos Magnoliae mentioned component account for 15% altogether in 1: 1 ratio;
Technological process is identical with embodiment 1.
Embodiment 3:
A; Rosehips oil 18% Radix Oenotherae erythrosepalae oil 36% Semen pruni armeniacae oil 36%
B: Olibanum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Chuanxiong, Myrrha, Rhizoma Et Radix Notopterygii, Lignum Pini Nodi, Folium eucalypti globueli (Eucalyptus globulus Labill.) Herba Menthae Flos Magnoliae mentioned component account for 10% altogether in 1: 1 ratio;
Technological process is identical with embodiment 1.
Clinical experiment: extract 66 routine acute lumbar muscle sprains, be divided into two groups at random, data are as follows:
| The recovery from illness natural law | The 1st day | The 2nd day | The 3rd day | The 4th day |
| Experimental group | 8(24.2％)? | 21(63.6％)? | ?3(9％)? | 1(3％)? |
| Contrast groups | 4(12.1％)? | 7(21.2％)? | ?9(27.3％)? | 13(39.4％)? |
Claims (2)
1. health care essential oil of magnolia flower, its raw material is A, B component; Wherein the A component is a base oil, accounts for 70%-95%, is Rosehips oil, Radix Oenotherae erythrosepalae oil and Semen pruni armeniacae oil, and three's ratio is 1: 2: 2; Described B component proportion is 5%-30%, is Olibanum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Chuanxiong, Myrrha, Rhizoma Et Radix Notopterygii, Lignum Pini Nodi, Folium eucalypti globueli (Eucalyptus globulus Labill.), Herba Menthae and the Flos Magnoliae of ratio equal portions.
2. a kind of health care essential oil of magnolia flower according to claim 1 is characterized in that: the optimum scope of described A, B component is respectively 90%-95% and 5%-10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102198327A CN101428080B (en) | 2008-12-10 | 2008-12-10 | Health care essential oil of magnolia flower |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102198327A CN101428080B (en) | 2008-12-10 | 2008-12-10 | Health care essential oil of magnolia flower |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101428080A CN101428080A (en) | 2009-05-13 |
| CN101428080B true CN101428080B (en) | 2011-06-01 |
Family
ID=40643848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102198327A Expired - Fee Related CN101428080B (en) | 2008-12-10 | 2008-12-10 | Health care essential oil of magnolia flower |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101428080B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103609750A (en) * | 2013-12-06 | 2014-03-05 | 杨传德 | Health-care sesame oil with effects of harmonizing stomach and relieving pain |
| CN104762136A (en) * | 2015-04-07 | 2015-07-08 | 范永启 | Compound tea tree essential oil with sterilization and disinfection effects and preparation method of compound tea tree essential oil |
| CN105126037B (en) * | 2015-10-10 | 2018-08-14 | 皖南医学院 | A kind of ointment for treating bone fracture and injury of the extract containing natural component and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1248454A (en) * | 1998-09-18 | 2000-03-29 | 刘维增 | Jingtongtie plaster for treating cervicodynia and preparation process |
| CN1333028A (en) * | 2000-07-12 | 2002-01-30 | 赵树人 | External liniment for treating rheumatic arthritis |
| CN101293036A (en) * | 2007-11-09 | 2008-10-29 | 北京中科雍和医药技术有限公司 | Compound essential oil for treating common cold, allergic rhinitis and pharyngitis, and preparation method thereof |
-
2008
- 2008-12-10 CN CN2008102198327A patent/CN101428080B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1248454A (en) * | 1998-09-18 | 2000-03-29 | 刘维增 | Jingtongtie plaster for treating cervicodynia and preparation process |
| CN1333028A (en) * | 2000-07-12 | 2002-01-30 | 赵树人 | External liniment for treating rheumatic arthritis |
| CN101293036A (en) * | 2007-11-09 | 2008-10-29 | 北京中科雍和医药技术有限公司 | Compound essential oil for treating common cold, allergic rhinitis and pharyngitis, and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 宋希明.植物精油的药用价值与特性.《海峡药学》.2007,第19卷(第5期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101428080A (en) | 2009-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169544C (en) | Fracture-setting silky fowl ointment and its prepn | |
| CN100402066C (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN101244252B (en) | Chinese medicine label for eliminating ache and preparation thereof | |
| CN1317027C (en) | Chinese medicine for treating depression | |
| CN102091272B (en) | Black plaster product for bone fracture and preparation method thereof | |
| CN1424024A (en) | External used paste for orthopedic diseases | |
| CN101518600B (en) | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof | |
| CN105943642A (en) | Hot compress traditional Chinese medicinal composition for promoting rehabilitation of neck-shoulder and lumbocrural pain | |
| CN101062208A (en) | Milkwort pills for relieving uneasiness | |
| CN101428080B (en) | Health care essential oil of magnolia flower | |
| CN100478010C (en) | Recipe of Chinese medicine for treating psoriasis | |
| CN100534511C (en) | Combined Chinese-Western medicine mixture for treating mycotic skin disease, and its use method | |
| CN100473402C (en) | Medicine for treating protrusion of intervetebral disc and cervical vertebra disease | |
| CN101244235B (en) | Scraping oil, preparation method and application thereof | |
| CN102008562A (en) | External plaster for treating scapulohumeral periarthritis | |
| CN101721537A (en) | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis | |
| CN1478526A (en) | Pure medicated wine | |
| CN101181384A (en) | Chinese medicine decoction for curing rheumatic arteritis and atrophic arthritis | |
| CN102961483A (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN1260984A (en) | Exterior-applied Chinese medicine for treating trauma | |
| CN104258299A (en) | Traditional Chinese medicine for treating mumps | |
| CN1814218A (en) | Hormone external-dressing agent for treating dermatitis | |
| CN103656492A (en) | Traditional Chinese medicine for external use for treating headache | |
| CN1201773C (en) | Process of oil for dispelling wind | |
| CN1241580C (en) | Medicinal composition for treating hypersteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110601 Termination date: 20151210 |
|
| EXPY | Termination of patent right or utility model |